NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.8800
+0.0030 (0.34%)
At close: May 8, 2026, 4:00 PM EDT
0.8700
-0.0100 (-1.14%)
After-hours: May 8, 2026, 6:49 PM EDT
NeuroSense Therapeutics Employees
NeuroSense Therapeutics had 17 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
17
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$654,412
Market Cap
31.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | 0 | - |
| Dec 31, 2024 | 17 | -1 | -5.56% |
| Dec 31, 2023 | 18 | 4 | 28.57% |
| Dec 31, 2022 | 14 | 3 | 27.27% |
| Dec 31, 2021 | 11 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| IGC Pharma | 70 |
| Werewolf Therapeutics | 39 |
| Senti Biosciences Holdings | 39 |
| Lisata Therapeutics | 21 |
| Tevogen Bio Holdings | 18 |
| Quantum BioPharma | 17 |
| BriaCell Therapeutics | 16 |
NRSN News
- 10 days ago - NeuroSense Announces Pricing of Insider-Led PIPE Financing - PRNewsWire
- 12 days ago - NeuroSense announces departure of Chief Medical Officer - TheFly
- 4 weeks ago - NeuroSense granted Brazilian patent covering PrimeC composition - TheFly
- 4 weeks ago - NeuroSense Granted Brazilian Patent Covering PrimeC Composition - PRNewsWire
- 5 weeks ago - NeuroSense Therapeutics Announces Receipt of Nasdaq Notifications Regarding Minimum Bid Price and Market Value Requirements - PRNewsWire
- 5 weeks ago - NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update - PRNewsWire
- 6 weeks ago - NeuroSense Advances Toward Key Regulatory Milestones with Strengthened Data Package and Near-Term Alzheimer's Readout - PRNewsWire
- 7 weeks ago - PrimeC New Data to Be Presented at AD/PD™ 2026 Conference - PRNewsWire